Literature DB >> 17500061

Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62.

Yumei Leng1, Cheng Cao, Jian Ren, Lei Huang, Dongshu Chen, Masaki Ito, Donald Kufe.   

Abstract

The MUC1 heterodimeric transmembrane protein is aberrantly overexpressed by most human carcinomas. The MUC1 C-terminal subunit (MUC1-C) is devoid of a classical nuclear localization signal and is targeted to the nucleus by an unknown mechanism. The present results demonstrate that MUC1-C associates with importin beta and not importin alpha. The results also show that, like importin beta, MUC1-C binds to Nup62 (nucleoporin p62). MUC1-C binds directly to the Nup62 central domain and indirectly to the Nup62 C-terminal alpha-helical coiled-coil domain. We demonstrate that MUC1-C forms oligomers and that oligomerization is necessary for binding to Nup62. The MUC1-C cytoplasmic domain contains a CQC motif that when mutated to AQA abrogates oligomerization and binding to Nup62. Stable expression of MUC1 with the CQC --> AQA mutations was associated with targeting to the cell membrane and cytosol and attenuation of nuclear localization. The results further show that expression of MUC1(CQC-AQA) attenuates MUC1-induced (i) transcriptional coactivation, (ii) anchorage-independent growth, and (iii) tumorigenicity. These findings indicate that the MUC1-C oncoprotein is imported to the nucleus by a pathway involving Nup62.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17500061     DOI: 10.1074/jbc.M703222200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  97 in total

1.  A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain.

Authors:  Govind Panchamoorthy; Hala Rehan; Akriti Kharbanda; Rehan Ahmad; Donald Kufe
Journal:  Hybridoma (Larchmt)       Date:  2011-12

Review 2.  Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.

Authors:  Partha Mukhopadhyay; Subhankar Chakraborty; Moorthy P Ponnusamy; Imayavaramban Lakshmanan; Maneesh Jain; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2011-01-26

3.  The MUC1-C oncoprotein as a target in hematologic malignancies.

Authors:  Jeffrey Schlom
Journal:  Cancer Biol Ther       Date:  2010-09-26       Impact factor: 4.742

4.  MUC1-C Oncoprotein Interacts Directly with ATM and Promotes the DNA Damage Response to Ionizing Radiation.

Authors:  Lei Huang; Xiaodong Liao; Michael Beckett; Yuan Li; Kum Kum Khanna; Zhugang Wang; Surender Kharbanda; Ralph Weichselbaum; Donald Kufe
Journal:  Genes Cancer       Date:  2010-03

5.  MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.

Authors:  Hasan Rajabi; Caining Jin; Rehan Ahmad; Cain McClary; Maya Datt Joshi; Donald Kufe
Journal:  Genes Cancer       Date:  2010-01-01

6.  MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells.

Authors:  Li Yin; Zekui Wu; David Avigan; Jacalyn Rosenblatt; Richard Stone; Surender Kharbanda; Donald Kufe
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

7.  MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.

Authors:  Hasan Rajabi; Rehan Ahmad; Caining Jin; Michio Kosugi; Maroof Alam; Maya Datt Joshi; Donald Kufe
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

8.  MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells.

Authors:  Suiyang Liu; Li Yin; Dina Stroopinsky; Hasan Rajabi; Alexandre Puissant; Kimberly Stegmaier; David Avigan; Surender Kharbanda; Donald Kufe; Richard Stone
Journal:  Blood       Date:  2013-11-26       Impact factor: 22.113

9.  MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.

Authors:  Maroof Alam; Rehan Ahmad; Hasan Rajabi; Akriti Kharbanda; Donald Kufe
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

10.  MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.

Authors:  H Rajabi; M Alam; H Takahashi; A Kharbanda; M Guha; R Ahmad; D Kufe
Journal:  Oncogene       Date:  2013-04-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.